2010 Dale E. Wurster Research Award in Pharmaceutics
Theodore Randolph, Ph.D.
Ted Randolph received his Ph.D. in Chemical Engineering at the University of California, Berkeley. He worked as a post‐doctoral fellow at the Ecole Polytechnique Federale de Lausanne, and then joined the Department of Chemical Engineering at Yale University as an Assistant Professor. After promotion to Associate Professor, he was named to Yale’s first John J. Lee Junior Professorship Chair in Chemical Engineering. In 1993, Dr. Randolph accepted the Patton Associate Professorship Chair in the Department of Chemical Engineering at the University of Colorado. He currently serves as the Gillespie Professor of Bioengineering, co‐Director of the University of Colorado’s Center for Pharmaceutical Biotechnology, and Director of the NIH Leadership Training in Pharmaceutical Biotechnology Program. Dr. Randolph is a National Science Foundation Presidential Young Investigator, and received the AIChE Professional Progress Award and the American Pharmacist’s Ebert Prize. His research interests include biopharmaceutical formulation, lyophilization of proteins, protein‐solvent interactions in non‐aqueous environments, and protein refolding. Dr. Randolph is an inventor on numerous patents, some of which form the basis for two companies that he has founded: RxKinetix, Inc. (now owned by Endo Pharmaceuticals), a company formed to commercialize new extended‐release drug delivery technologies, and BaroFold Inc., a company that uses high‐pressure protein refolding technology to develop and produce new protein therapeutics.